0001761906-22-000002.txt : 20221202 0001761906-22-000002.hdr.sgml : 20221202 20221202134103 ACCESSION NUMBER: 0001761906-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221202 DATE AS OF CHANGE: 20221202 EFFECTIVENESS DATE: 20221202 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Spiral Therapeutics Inc CENTRAL INDEX KEY: 0001761906 IRS NUMBER: 811556641 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-466418 FILM NUMBER: 221441345 BUSINESS ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 206 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-453-0893 MAIL ADDRESS: STREET 1: 6000 SHORELINE COURT STREET 2: SUITE 206 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 D 1 primary_doc.xml X0708 D LIVE 0001761906 Spiral Therapeutics Inc 6000 SHORELINE COURT SUITE 206 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 650-453-0893 DELAWARE None None Corporation true HUGO PERIS 6000 SHORELINE COURT SUITE 206 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Executive Officer Director ANTHONY ADAMIS 6000 SHORELINE COURT SUITE 206 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Director EUGENE DE JUAN 6000 SHORELINE COURT SUITE 206 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Director GUY JEAN SAVOIR GARCIA 6000 SHORELINE COURT SUITE 206 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Director ANGELA MACFARLANE 6000 SHORELINE COURT SUITE 206 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Director GUY P. NOHRA 6000 SHORELINE COURT SUITE 206 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Director DIAMANTIS XYLAS 6000 SHORELINE COURT SUITE 206 SOUTH SAN FRANCISCO CA CALIFORNIA 94080 Director Other Health Care Decline to Disclose 06b false 2022-10-18 false true true Sale and issuance of (i) Series A-4 Preferred Stock, (ii) Series A-5 Preferred Stock, and (iii) Common Stock issuable upon conversion of Series A-4 Preferred Stock and Series A-5 Preferred Stock. false 0 8245175 1265343 6979832 Total Offering Amount includes conversion of outstanding indebtedness in the amount of $5,745,172.48. false 12 0 0 0 true Proceeds will be used for general corporate purposes including, but not limited to, executive salaries. false Spiral Therapeutics Inc /s/Hugo Peris Hugo Peris President and CEO 2022-11-29